Código QR (código de barras bidimensional)

Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer

<b>Background:</b> Monoclonal antibodies against PD-1 or PD-L1 have been established in clinical practice for the treatment of both early and advanced/metastatic triple-negative breast cancer. Beyond the established immune checkpoints (ICPs) (PD-1 and CTLA-4), additional ICPs, such as lymphocyte act...

תיאור מלא

שמור ב:
Principais autores: Anne-Sophie Heimes, Katrin Almstedt, Slavomir Krajnak, Anne Runkel, Annika Droste, Roxana Schwab, Kathrin Stewen, Antje Lebrecht, Marco J. Battista, Walburgis Brenner, Annette Hasenburg, Mathias Gehrmann, Jan G. Hengstler, Marcus Schmidt
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2022-10-01
סדרה:Biomedicines
נושאים:
LAG-3
immune checkpoints
immunotherapy
breast cancer
גישה מקוונת:https://www.mdpi.com/2227-9059/10/10/2656
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים